Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 4.12 | +8.1 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 4.02 | +10.7 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 18 Tagen @ 4.07 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 4.08 | EMA50: 4.07 | |
| MACD-Histogramm | Bullisch | 10 % | 0.028 | Bullisch | |
| RSI(14) | Neutral | 10 % | 58.6 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 78.3 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 19.8 | +DI: 35.7 / −DI: 19.6 | |
| Z-Score(60) | Neutral | 5 % | 1.30 | In Range | |
| 52W-Position | Neutral | 5 % | 79.9 % | Hoch 5.21 / Tief 1.42 | |
| Bollinger(20,2σ) | Neutral | 5 % | 78.1 % | Upper 4.71 / Mid 4.12 / Lower 3.52 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0096 | R²=0.24 / annualisiert +60.1 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | Sabzevari Helen | Officer, President and CEO | Open Market Sale | -119.250 | 4,36 | -519.930,00 | -33,6% | |
| 2026-05-28 | Tennant Phil | Officer, Chief Commercial Officer | Open Market Sale | -30.272 | 4,36 | -131.985,92 | -8,5% | |
| 2026-05-28 | Thomasian Harry Jr. | Officer, Chief Financial Officer | Open Market Sale | -41.884 | 4,36 | -182.614,24 | -11,8% | |
| 2026-05-28 | Shah Rutul R | Officer, Chief Operating Officer | Open Market Sale | -42.703 | 4,36 | -186.185,08 | -12,0% | |
| 2026-05-28 | Lehr Donald P. | Officer, Chief Legal Officer | Open Market Sale | -29.131 | 4,36 | -127.011,16 | -8,2% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -168.794 | 3,30 | -557.020,20 | -36,0% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -152.063 | 3,30 | -501.807,90 | -32,4% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -50.797 | 3,30 | -167.630,10 | -10,8% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -47.101 | 3,30 | -155.433,30 | -10,0% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -23.789 | 3,30 | -78.503,70 | -5,1% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -38.976 | 3,30 | -128.620,80 | -8,3% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -2.334.420 | 3,30 | -7.703.586,00 | -497,9% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -1.108.998 | 3,30 | -3.659.693,40 | -236,6% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -426.199 | 3,30 | -1.406.456,70 | -90,9% | |
| 2026-03-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -370.847 | 3,30 | -1.223.795,10 | -79,1% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -956.200 | 4,18 | -3.996.916,00 | -258,4% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -5.958 | 4,18 | -24.904,44 | -1,6% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -9.931 | 4,18 | -41.511,58 | -2,7% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -11.917 | 4,18 | -49.813,06 | -3,2% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -12.909 | 4,18 | -53.959,62 | -3,5% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -38.729 | 4,18 | -161.887,22 | -10,5% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -42.702 | 4,18 | -178.494,36 | -11,5% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -94.341 | 4,18 | -394.345,38 | -25,5% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -159.321 | 4,18 | -665.961,78 | -43,0% | |
| 2025-12-22 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -555.119 | 4,18 | -2.320.397,42 | -150,0% | |
| 2025-12-12 | KINDLER JEFFREY B | Director | Open Market Sale | -235.467 | 3,63 | -855.899,00 | -55,3% | |
| 2025-11-21 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -937.308 | 3,83 | -3.589.889,64 | -232,0% | |
| 2025-11-20 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -942.832 | 4,08 | -3.846.754,56 | -248,6% | |
| 2025-11-19 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -1.086.153 | 4,47 | -4.855.103,91 | -313,8% | |
| 2025-09-30 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -1.809.667 | 3,41 | -6.170.964,47 | -398,9% | |
| 2025-09-30 | KINDLER JEFFREY B | Director | Open Market Sale | -106.837 | 3,38 | -361.109,06 | -23,3% | |
| 2025-09-29 | KINDLER JEFFREY B | Director | Open Market Sale | -67.523 | 3,60 | -243.082,80 | -15,7% | |
| 2025-09-29 | Tennant Phil | Officer, Chief Commercial Officer | Open Market Purchase | 6.000 | 3,58 | 21.480,00 | +1,4% | |
| 2025-09-26 | Shah Rutul R | Officer, Chief Operating Officer | Open Market Purchase | 2.000 | 3,40 | 6.800,00 | +0,4% | |
| 2025-09-26 | Thomasian Harry Jr. | Officer, Chief Financial Officer | Open Market Purchase | 2.932 | 3,42 | 10.027,44 | +0,6% | |
| 2025-09-25 | Thomasian Harry Jr. | Officer, Chief Financial Officer | Open Market Purchase | 8.284 | 3,62 | 29.988,08 | +1,9% | |
| 2025-09-19 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -3.596.892 | 3,68 | -13.236.562,56 | -855,6% | |
| 2025-09-18 | KIRK RANDAL J | Director, 10% Owner | Open Market Sale | -1.403.360 | 3,86 | -5.416.969,60 | -350,1% | |
| 2025-09-04 | AGEE NANCY H | Director | Open Market Purchase | 15.000 | 4,60 | 69.000,00 | +4,5% | |
| 2025-08-28 | AGEE NANCY H | Director | Open Market Purchase | 10.645 | 4,65 | 49.490,73 | +3,2% | |
| 2025-08-19 | AGEE NANCY H | Director | Open Market Purchase | 15.360 | 3,20 | 49.152,00 | +3,2% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Patient Capital Management, LLC | 17.817.387 | 18.673.466 | -856.079 | 68.953.288 | Reduziert | -4,6% | |
| BlackRock, Inc. | 15.223.191 | 15.094.359 | 128.832 | 58.913.751 | Aufgestockt | +0,9% | |
| VANGUARD GROUP INC | 10.479.452 | 0 | 10.479.452 | 43.804.109 | Neu | +100,0% | |
| STATE STREET CORP | 10.890.124 | 10.824.860 | 65.264 | 42.144.780 | Aufgestockt | +0,6% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.148.996 | 0 | 7.148.996 | 27.666.615 | Neu | +100,0% | |
| Diametric Capital, LP | 6.801.788 | 3.847.024 | 2.954.764 | 26.322.919 | Aufgestockt | +76,8% | |
| Point72 Asset Management, L.P. | 6.741.861 | 13.821.941 | -7.080.080 | 26.091.002 | Reduziert | -51,2% | |
| TANG CAPITAL MANAGEMENT LLC | 6.417.500 | 5.617.500 | 800.000 | 24.835.725 | Aufgestockt | +14,2% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4.613.429 | 4.462.078 | 151.351 | 17.856.721 | Aufgestockt | +3,4% | |
| Occam Crest Management LP | 4.269.051 | 3.502.039 | 767.012 | 16.521.227 | Aufgestockt | +21,9% | |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3.592.730 | 3.600.195 | -7.465 | 13.903.865 | Reduziert | -0,2% | |
| Boxer Capital Management, LLC | 3.500.000 | 1.375.000 | 2.125.000 | 13.545.000 | Aufgestockt | +154,5% | |
| GOLDMAN SACHS GROUP INC | 3.350.477 | 2.173.933 | 1.176.544 | 12.966.346 | Aufgestockt | +54,1% | |
| SymBiosis Capital Partners, LLC | 3.000.000 | 0 | 3.000.000 | 12.540.000 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 3.002.283 | 3.686.384 | -684.101 | 11.618.835 | Reduziert | -18,6% | |
| FRANKLIN RESOURCES INC | 2.633.780 | 468.038 | 2.165.742 | 10.192.728 | Aufgestockt | +462,7% | |
| MORGAN STANLEY | 2.414.322 | 3.193.523 | -779.201 | 9.343.427 | Reduziert | -24,4% | |
| JANE STREET GROUP, LLC | 2.259.290 | 338.700 | 1.920.590 | 8.743.452 | Aufgestockt | +567,0% | |
| FMR LLC | 1.998.596 | 4.652.179 | -2.653.583 | 7.734.566 | Reduziert | -57,0% | |
| Caption Management, LLC | 1.806.616 | 1.100.000 | 706.616 | 6.991.604 | Aufgestockt | +64,2% | |
| NORTHERN TRUST CORP | 1.611.790 | 1.579.142 | 32.648 | 6.237.627 | Aufgestockt | +2,1% | |
| BANK OF AMERICA CORP /DE/ | 1.471.279 | 2.188.606 | -717.327 | 5.693.849 | Reduziert | -32,8% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.460.620 | 1.506.755 | -46.135 | 5.652.599 | Reduziert | -3,1% | |
| Woodline Partners LP | 1.401.412 | 1.400.961 | 451 | 5.423.464 | Aufgestockt | 0,0% | |
| PRELUDE CAPITAL MANAGEMENT, LLC | 1.270.053 | 649.974 | 620.079 | 4.915.105 | Aufgestockt | +95,4% | |
| Parkman Healthcare Partners LLC | 1.002.826 | 0 | 1.002.826 | 4.191.813 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.027.511 | 1.200.280 | -172.769 | 3.976.467 | Reduziert | -14,4% | |
| JPMORGAN CHASE & CO | 914.919 | 0 | 914.919 | 3.824.362 | Neu | +100,0% | |
| Corient Private Wealth LLC | 911.206 | 431.710 | 479.496 | 3.526.368 | Aufgestockt | +111,1% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 846.000 | 846.000 | 0 | 3.274.020 | Unverändert | 0,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 793.773 | 3.601.674 | -2.807.901 | 3.071.902 | Reduziert | -78,0% | |
| LexAurum Advisors, LLC | 689.413 | 0 | 689.413 | 2.668.028 | Neu | +100,0% | |
| UBS Group AG | 686.084 | 891.428 | -205.344 | 2.655.145 | Reduziert | -23,0% | |
| GMT CAPITAL CORP | 668.830 | 0 | 668.830 | 2.588.372 | Neu | +100,0% | |
| Lansing Street Advisors | 553.663 | 547.038 | 6.625 | 2.142.676 | Aufgestockt | +1,2% | |
| Nuveen, LLC | 534.011 | 528.959 | 5.052 | 2.066.623 | Aufgestockt | +1,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 508.434 | 482.947 | 25.487 | 1.967.639 | Aufgestockt | +5,3% | |
| BARCLAYS PLC | 491.696 | 865.378 | -373.682 | 1.902.863 | Reduziert | -43,2% | |
| Informed Momentum Co LLC | 405.001 | 0 | 405.001 | 1.692.904 | Neu | +100,0% | |
| GLR Partners, LLC | 412.047 | 0 | 412.047 | 1.594.622 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 395.695 | 0 | 395.695 | 1.531.340 | Neu | +100,0% | |
| CITIGROUP INC | 381.365 | 115.707 | 265.658 | 1.475.882 | Aufgestockt | +229,6% | |
| Cetera Investment Advisers | 374.514 | 371.264 | 3.250 | 1.449.369 | Aufgestockt | +0,9% | |
| SIMPLEX TRADING, LLC | 364.760 | 359.463 | 5.297 | 1.411.621 | Aufgestockt | +1,5% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 354.559 | 233.847 | 120.712 | 1.372.144 | Aufgestockt | +51,6% | |
| Swiss National Bank | 349.000 | 349.000 | 0 | 1.350.630 | Unverändert | 0,0% | |
| Rafferty Asset Management, LLC | 319.212 | 374.202 | -54.990 | 1.235.350 | Reduziert | -14,7% | |
| CIBC Bancorp USA Inc. | 301.988 | 0 | 301.988 | 1.168.694 | Neu | +100,0% | |
| CIBC Private Wealth Group LLC | 274.712 | 0 | 274.712 | 1.148.296 | Neu | +100,0% | |
| Voleon Capital Management LP | 274.872 | 464.814 | -189.942 | 1.063.755 | Reduziert | -40,9% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| Patient Capital Management, LLC | 17.817.387 | 18.673.466 | -4,6% | 68.953.288 | 13,62 |
| BlackRock, Inc. | 15.223.191 | 15.094.359 | +0,9% | 58.913.751 | 11,64 |
| STATE STREET CORP | 10.890.124 | 10.824.860 | +0,6% | 42.144.780 | 8,32 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.148.996 | 0 | +100,0% | 27.666.615 | 5,46 |
| Diametric Capital, LP | 6.801.788 | 3.847.024 | +76,8% | 26.322.919 | 5,20 |
| Point72 Asset Management, L.P. | 6.741.861 | 13.821.941 | -51,2% | 26.091.002 | 5,15 |
| TANG CAPITAL MANAGEMENT LLC | 6.417.500 | 5.617.500 | +14,2% | 24.835.725 | 4,91 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.613.429 | 4.462.078 | +3,4% | 17.856.721 | 3,53 |
| Occam Crest Management LP | 4.269.051 | 3.502.039 | +21,9% | 16.521.227 | 3,26 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3.592.730 | 3.600.195 | -0,2% | 13.903.865 | 2,75 |
| Boxer Capital Management, LLC | 3.500.000 | 1.375.000 | +154,5% | 13.545.000 | 2,68 |
| GOLDMAN SACHS GROUP INC | 3.350.477 | 2.173.933 | +54,1% | 12.966.346 | 2,56 |
| CITADEL ADVISORS LLC | 3.002.283 | 3.686.384 | -18,6% | 11.618.835 | 2,29 |
| FRANKLIN RESOURCES INC | 2.633.780 | 468.038 | +462,7% | 10.192.728 | 2,01 |
| MORGAN STANLEY | 2.414.322 | 3.193.523 | -24,4% | 9.343.427 | 1,85 |
| JANE STREET GROUP, LLC | 2.259.290 | 338.700 | +567,0% | 8.743.452 | 1,73 |
| FMR LLC | 1.998.596 | 4.652.179 | -57,0% | 7.734.566 | 1,53 |
| Caption Management, LLC | 1.806.616 | 1.100.000 | +64,2% | 6.991.604 | 1,38 |
| NORTHERN TRUST CORP | 1.611.790 | 1.579.142 | +2,1% | 6.237.627 | 1,23 |
| BANK OF AMERICA CORP /DE/ | 1.471.279 | 2.188.606 | -32,8% | 5.693.849 | 1,12 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 203 | 145,0 | 556 |
| 31.12.2025 | ✓ | 178 | 144,5 | 603 |
| 30.09.2025 | ✓ | 171 | 128,4 | 421 |
| 30.06.2025 | ✓ | 145 | 85,6 | 119 |
| 31.03.2025 | ✓ | 137 | 85,1 | 130 |
| 31.12.2024 | ✓ | 130 | 77,8 | 86 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| SymBiosis Capital Partners, LLC | 3.000.000 | 12.540.000 |
| Woodline Partners LP | 1.400.961 | 5.856.017 |
| Swiss National Bank | 349.000 | 1.458.820 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 233.847 | 977.481 |
| Impala Asset Management LLC | 165.000 | 689.700 |
| Investment Insight Wealth Management, LLC | 105.906 | 442.687 |
| JANUS HENDERSON GROUP PLC | 89.000 | 371.575 |
| Virtus Investment Advisers, LLC | 72.095 | 301.357 |
| VARCOV Co. | 53.522 | 223.722 |
| Mitsubishi UFJ Asset Management Co., Ltd. | 49.607 | 212.318 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 13.821.941 | 11.080.875 | +404.3 % | 57.775.713 |
| STATE STREET CORP | 10.824.860 | 6.335.033 | +141.1 % | 45.247.915 |
| FMR LLC | 4.652.179 | 4.535.517 | +3887.7 % | 19.446.108 |
| BlackRock, Inc. | 15.094.359 | 2.944.404 | +24.2 % | 63.094.420 |
| Diametric Capital, LP | 3.847.024 | 2.872.796 | +294.9 % | 16.080.560 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3.601.674 | 1.559.164 | +76.3 % | 15.054.997 |
| VANGUARD GROUP INC | 10.479.452 | 1.537.167 | +17.2 % | 43.804.109 |
| GOLDMAN SACHS GROUP INC | 2.173.933 | 1.440.446 | +196.4 % | 9.087.040 |
| MORGAN STANLEY | 3.193.523 | 1.211.879 | +61.2 % | 13.348.930 |
| Occam Crest Management LP | 3.502.039 | 795.639 | +29.4 % | 14.797.769 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Patient Capital Management, LLC | 18.673.466 | -7.787.382 | -29.4 % | 78.055.089 |
| TANG CAPITAL MANAGEMENT LLC | 5.617.500 | -6.782.500 | -54.7 % | 23.481.150 |
| Caption Management, LLC | 1.100.000 | -3.427.500 | -75.7 % | 4.598.000 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.200.280 | -1.650.995 | -57.9 % | 5.017.170 |
| Parkman Healthcare Partners LLC | 1.002.826 | -1.098.889 | -52.3 % | 4.191.813 |
| JANE STREET GROUP, LLC | 338.700 | -555.203 | -62.1 % | 1.415.766 |
| Corient Private Wealth LLC | 431.710 | -365.861 | -45.9 % | 1.804.550 |
| GROUP ONE TRADING LLC | 427.245 | -318.455 | -42.7 % | 1.785.884 |
| BANK OF AMERICA CORP /DE/ | 2.188.606 | -317.386 | -12.7 % | 9.148.372 |
| Informed Momentum Co LLC | 405.001 | -272.369 | -40.2 % | 1.692.904 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Point72 Asset Management, L.P. | Passiv (13G/A) | 1,90 % | 6.741.861 | -3,30 pp | |
| 15.05.2026 | Steven A. Cohen | Passiv (13G/A) | 1,90 % | 6.741.861 | -3,30 pp | |
| 15.05.2026 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 1,90 % | 6.741.861 | -3,30 pp | |
| 31.03.2026 | THIRD SECURITY, LLC | Aktivist (13D/A) | 5,90 % | 21.843.458 | -0,70 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 31.03.2026 | RANDAL J. KIRK | Aktivist (13D/A) | 35,90 % | 133.956.416 | -2,20 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 31.03.2026 | R.J. KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 26,10 % | 97.339.485 | -0,50 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 13.02.2026 | Patient Opportunity Trust, a Series of Advisor Managed Portfolios | Passiv (13G/A) | 7,80 % | 27.617.612 | -3,20 pp | |
| 13.02.2026 | Patient Capital Management, LLC | Passiv (13G/A) | 10,20 % | 36.006.800 | -3,40 pp | |
| 23.01.2026 | Point72 Asset Management, L.P. | Passiv (13G) | 5,20 % | 18.383.242 | Neu | |
| 23.01.2026 | Point72 Capital Advisors, Inc. | Passiv (13G) | 5,20 % | 18.383.242 | Neu | |
| 23.01.2026 | Steven A. Cohen | Passiv (13G) | 5,20 % | 18.383.242 | Neu | |
| 21.11.2025 | RANDAL J. KIRK | Aktivist (13D/A) | 38,10 % | 141.519.399 | -1,30 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 21.11.2025 | THIRD SECURITY, LLC | Aktivist (13D/A) | 6,60 % | 24.487.991 | -0,80 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 21.11.2025 | R.J. KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 26,60 % | 98.831.434 | 0,00 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 30.10.2025 | Patient Capital Management, LLC | Passiv (13G/A) | 13,60 % | 45.223.463 | +7,07 pp | |
| 30.10.2025 | Patient Opportunity Trust, a Series of Advisor Managed Portfolios | Passiv (13G/A) | 11,00 % | 35.786.370 | Neu | |
| 23.09.2025 | William H. Miller III Living Trust dated April 17, 2017 | Passiv (13G) | 9,20 % | 34.051.925 | Neu | |
| 19.09.2025 | RANDAL J. KIRK | Aktivist (13D/A) | 39,40 % | 146.295.359 | -0,40 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 19.09.2025 | SUNSET 2020 LLC | Aktivist (13D/A) | 4,40 % | 16.406.828 | -1,20 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 19.09.2025 | R.J. KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 26,60 % | 98.831.434 | +4,60 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 19.09.2025 | THIRD SECURITY, LLC | Aktivist (13D/A) | 7,40 % | 27.454.284 | -3,70 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 12.02.2025 | Patient Capital Management, LLC | Passiv (13G/A) | 6,53 % | 17.683.758 | +0,11 pp | |
| 30.12.2024 | THIRD SECURITY, LLC | Aktivist (13D/A) | 11,10 % | 32.454.536 | -7,10 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 30.12.2024 | RANDAL J. KIRK | Aktivist (13D/A) | 39,80 % | 116.844.357 | +1,50 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 30.12.2024 | R.J. KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 22,00 % | 64.547.214 | +9,60 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 30.12.2024 | SUNSET 2020 LLC | Aktivist (13D/A) | 5,60 % | 16.406.828 | -0,90 pp | Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The … |
| 13.08.2024 | THIRD | Aktivist (13D/A) | 11,30 % | 32.454.536 | -1,50 pp | |
| 13.08.2024 | KAPITAL | Aktivist (13D/A) | 4,70 % | 13.520.789 | -0,60 pp | |
| 13.08.2024 | KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 22,40 % | 64.547.214 | +6,20 pp | |
| 13.08.2024 | RANDAL | Aktivist (13D/A) | 40,50 % | 116.844.357 | +3,60 pp | |
| 13.08.2024 | SUNSET | Aktivist (13D/A) | 5,70 % | 16.406.828 | -0,80 pp | |
| 03.05.2024 | RANDAL | Aktivist (13D/A) | 36,90 % | 93.314.946 | Neu | |
| 03.05.2024 | THIRD | Aktivist (13D/A) | 12,80 % | 32.454.536 | Neu | |
| 03.05.2024 | KIRK DECLARATION OF TRUST | Aktivist (13D/A) | 16,20 % | 41.017.803 | Neu | |
| 03.05.2024 | SUNSET | Aktivist (13D/A) | 6,50 % | 16.406.828 | Neu | |
| 03.05.2024 | KAPITAL | Aktivist (13D/A) | 5,30 % | 13.520.789 | Neu | |
| 27.02.2024 | Patient Capital Management, LLC | Passiv (13G/A) | 6,42 % | 15.983.700 | 0,00 pp | |
| 27.02.2024 | Patient Opportunity Trust, a series of Advisor Managed Portfolios | Passiv (13G/A) | 5,22 % | 13.000.000 | Neu | |
| 14.02.2024 | Ares Trading SA | Passiv (13G/A) | 8,30 % | 206.471.521 | -1,62 pp | |
| 14.02.2024 | Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck | Passiv (13G/A) | 8,30 % | 206.471.523 | -1,62 pp |
Stammdaten
Precigen, Inc. entdeckt und entwickelt die nächste Generation von Gen- und Zelltherapien in den Vereinigten Staaten. Das Unternehmen bietet auch krankheitsmodifizierende Therapeutika; genetisch veränderte Schweine für Anwendungen in der regenerativen Medizin; und Reproduktions- und Embryotransfer-Technologien. Zusätzlich bietet das Unternehmen die UltraVector-Plattform an, die fortschrittliche DNA-Konstruktionstechnologien und rechnergestützte Modelle beinhaltet, um genetische Komponenten in komplexe Genexpressionsprogramme zu entwerfen und zu montieren; mbIL15, ein Gen, das die funktionalen Eigenschaften von Immunzellen verbessert; Sleeping Beauty, ein nicht-virales Transposon/Transposase-System; AttSite-Rekombinase, die DNA an spezifischen Stellen trennt und wieder verbindet; AdenoVerse-Technologieplattform, eine Bibliothek von konstruierten Adenovektoren-Serotypen; und L. lactis ist ein Bakterium der Lebensmittelsorte. Darüber hinaus bietet das Unternehmen RheoSwitch, ein induzierbares Genschaltersystem, das eine quantitative dosisabhängige Regulierung der Menge und des Zeitpunkts der Zielproteinexpression ermöglicht; Killschalter, um Zelltherapien selektiv in vivo zu eliminieren; gewebespezifische Promotoren; UltraCAR-T-Plattform zur Behandlung von Krebs; AdenoVerse Immunotherapy, eine Bibliothek proprietärer Adenovektoren für die Genabgabe; und ActoBiotics-Plattform, genetisch modifizierte Bakterien, die Proteine und Peptide an Mukosaoberflächen abgeben. Precigen, Inc. hat Kooperations- und Lizenzvereinbarungen mit Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; und Intrexon Energy Partners II, LLC. Das Unternehmen war früher unter dem Namen Intrexon Corporation bekannt und änderte seinen Namen im Januar 2020 in Precigen, Inc. Precigen, Inc. wurde 1998 gegründet und hat seinen Sitz in Germantown, Maryland.
Unternehmen & Branche
| Name | PRECIGEN, INC. |
|---|---|
| Ticker | PGEN |
| CIK | 0001356090 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 74017N105 |
|---|---|
| ISIN | US74017N1054 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,60 Mrd. USD |
| Beta | 1,09 |
Bewertung
| KBV (P/B) | 76,33 vs. 7,15 (2021) ▲ |
|---|---|
| KUV (P/S) | 164,82 vs. 53,76 (2021) ▲ |
| FCF-Rendite | -5,6 % vs. -8,2 % (2021) ▲ |
Qualität & Bilanz
| Operative Marge | -1.141,1 % |
|---|---|
| Nettomarge | -2.588,2 % vs. -646,0 % (2021) ▼ |
| ROIC | -210,3 % vs. -31,0 % (2021) ▼ |
| Zinsdeckungsgrad | -28,6 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 7,15 | 2,51 | 2,81 | 8,52 | 70,74 | |
| KUV (P/S) | 53,76 | 11,76 | 53,58 | 83,57 | 152,76 | |
| FCF-Rendite | -8,2 % | -22,1 % | -20,5 % | -23,4 % | -6,1 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | – | – | -1.602,5 % | -3.440,2 % | -1.141,1 % | |
| Nettomarge | -646,0 % | 105,2 % | -1.540,6 % | -3.216,2 % | -2.588,2 % | |
| ROIC | -31,0 % | 12,8 % | -76,4 % | -286,8 % | -210,3 % | |
| Zinsdeckungsgrad | – | – | -213,2 | – | -28,6 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 23.252.000 | -7.929.000 | -0,02 | 138.627.000 | 20.235.000 |
| 2025-12-31 | 10-K | 9.684.000 | -250.642.000 | -1,37 | 155.505.000 | 20.911.000 |
| 2025-09-30 | 10-Q | 2.922.000 | -146.344.000 | -1,06 | 171.264.000 | 41.868.000 |
| 2025-06-30 | 10-Q | 856.000 | -26.642.000 | -0,09 | 101.896.000 | -36.779.000 |
| 2025-03-31 | 10-Q | 1.341.000 | -54.153.000 | -0,18 | 128.787.000 | -14.060.000 |
| 2024-12-31 | 10-K | 3.925.000 | -126.235.000 | -0,47 | 145.266.000 | 38.513.000 |
| 2024-09-30 | 10-Q | 953.000 | -23.978.000 | -0,09 | 83.474.000 | 55.376.000 |
| 2024-06-30 | 10-Q | 31.000 | -58.792.000 | -0,23 | 73.160.000 | 43.170.000 |
| 2024-03-31 | 10-Q | 919.000 | -23.738.000 | -0,10 | 134.847.000 | 97.019.000 |
| 2023-12-31 | 10-K | 6.225.000 | -95.904.000 | -0,39 | 151.043.000 | 118.498.000 |
| 2023-09-30 | 10-Q | 82.000 | -19.795.000 | -0,08 | 190.688.000 | 147.678.000 |
| 2023-06-30 | 10-Q | 1.767.000 | -20.319.000 | -0,08 | 207.527.000 | 166.210.000 |
| 2023-03-31 | 10-Q | 1.851.000 | -22.734.000 | -0,10 | 241.546.000 | 184.133.000 |
| 2022-12-31 | 10-K | 26.909.000 | 28.317.000 | 0,14 | 215.977.000 | 126.259.000 |
| 2022-09-30 | 10-Q | 16.722.000 | 87.379.000 | 0,44 | 259.245.000 | 142.532.000 |
| 2022-07-31 | 10-K | 14.561.000 | ||||
| 2022-06-30 | 10-Q | 2.911.000 | -17.635.000 | -0,09 | 321.224.000 | 55.653.000 |
| 2022-03-31 | 10-Q | 5.513.000 | -19.251.000 | -0,10 | 335.568.000 | 73.836.000 |
| 2021-12-31 | 10-K | 14.267.000 | -92.166.000 | -0,47 | 359.856.000 | 107.348.000 |
| 2021-09-30 | 10-Q | 3.333.000 | -29.764.000 | -0,15 | 376.899.000 | 131.247.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| Product And Service | 7,9 Mio. | 3,9 Mio. | 6,2 Mio. | 33,3 % | +100,4% | |
| Product | 4,0 Mio. | 422.000 | 840.000 | 16,8 % | +841,9% | |
| Service | 3,9 Mio. | 3,5 Mio. | 5,3 Mio. | 16,5 % | +11,1% | |
| Service Exemplar | 3,9 Mio. | 3,5 Mio. | 5,3 Mio. | 16,5 % | +11,1% | |
| Papzimeos | 3,4 Mio. | – | – | 14,5 % | Neu | |
| Product Exemplar | 562.000 | 422.000 | 840.000 | 2,4 % | +33,2% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 13.05.2026 | 23,3 Mio. USD | -0,02 |
| Q3 2025 | 30.09.2025 | 13.11.2025 | – | -1,06 |
| Q2 2025 | 30.06.2025 | 12.08.2025 | – | -0,09 |
| Q1 2025 | 31.03.2025 | 13.05.2026 | 1,3 Mio. USD | -0,18 |
| Q3 2024 | 30.09.2024 | 13.11.2025 | – | -0,09 |
| Q2 2024 | 30.06.2024 | 12.08.2025 | – | -0,23 |
| Q1 2024 | 31.03.2024 | 14.05.2025 | – | -0,10 |
| Q3 2023 | 30.09.2023 | 14.11.2024 | – | -0,08 |
| Q2 2023 | 30.06.2023 | 14.08.2024 | 1,8 Mio. USD | -0,08 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 13.05.2026 | 10-Q | – | – | SEC » |
| 25.03.2026 | 10-K | 31.12.2025 | 84 Tage | SEC » |
| 13.11.2025 | 10-Q | 30.09.2025 | 44 Tage | SEC » |
| 12.08.2025 | 10-Q | 30.06.2025 | 43 Tage | SEC » |
| 14.05.2025 | 10-Q | 31.03.2025 | 44 Tage | SEC » |
| 28.04.2025 | 10-K/A | 31.12.2024 | 118 Tage | SEC » |
| 19.03.2025 | 10-K | 31.12.2024 | 78 Tage | SEC » |
| 14.11.2024 | 10-Q | 30.09.2024 | 45 Tage | SEC » |
| 14.08.2024 | 10-Q | 30.06.2024 | 45 Tage | SEC » |
| 14.05.2024 | 10-Q | 31.03.2024 | 44 Tage | SEC » |
| 29.04.2024 | 10-K/A | 31.12.2023 | 120 Tage | SEC » |
| 19.03.2024 | 10-K | 31.12.2023 | 79 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 10.05.2023 | 10-Q | 31.03.2023 | 40 Tage | SEC » |
| 06.03.2023 | 10-K | 31.12.2022 | 65 Tage | SEC » |
| 09.11.2022 | 10-Q | 30.09.2022 | 40 Tage | SEC » |
| 08.08.2022 | 10-Q | 30.06.2022 | 39 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 01.03.2022 | 10-K | 31.12.2021 | 60 Tage | SEC » |
| 08.11.2021 | 10-Q | 30.09.2021 | 39 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 01.03.2021 | 10-K | 31.12.2020 | 60 Tage | SEC » |
| 09.11.2020 | 10-Q | 30.09.2020 | 40 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Act ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 23.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 09.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 21.09.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers As… |
| 30.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-11 | 50 | 4,21 | 211 |
| 2026-05-08 | 9.880 | 4,15 | 41.002 |
| 2026-05-06 | 6.446 | 4,33 | 27.911 |
| 2026-04-22 | 1.571 | 3,98 | 6.253 |
| 2026-04-20 | 698 | 3,98 | 2.778 |
| 2026-04-16 | 83.232 | 3,90 | 324.605 |
| 2026-04-10 | 1.362 | 4,27 | 5.816 |
| 2026-04-09 | 902 | 4,12 | 3.716 |
| 2026-04-02 | 133.286 | 3,93 | 523.814 |
| 2026-04-01 | 216.498 | 3,87 | 837.847 |
| 2026-03-27 | 2.898 | 3,89 | 11.273 |
| 2026-03-18 | 193 | 3,54 | 683 |
| 2026-03-17 | 44.945 | 3,51 | 157.757 |
| 2026-03-16 | 44.514 | 3,51 | 156.244 |
| 2026-03-12 | 7.559 | 3,42 | 25.852 |
| 2026-03-11 | 960 | 3,51 | 3.370 |
| 2026-02-25 | 90 | 3,98 | 358 |
| 2026-02-19 | 430 | 4,88 | 2.098 |
| 2026-02-18 | 27.907 | 5,21 | 145.395 |
| 2026-02-13 | 18.248 | 4,74 | 86.496 |
| 2026-02-12 | 54.393 | 4,91 | 267.070 |
| 2026-02-11 | 9.720 | 4,66 | 45.295 |
| 2026-02-10 | 2.642 | 4,56 | 12.048 |
| 2026-02-06 | 72.184 | 4,24 | 306.060 |
| 2026-02-05 | 105.080 | 4,56 | 479.165 |
| 2026-02-04 | 4.459 | 4,80 | 21.403 |
| 2026-02-02 | 2.841 | 4,49 | 12.756 |
| 2026-01-30 | 1.275 | 4,53 | 5.776 |
| 2026-01-29 | 313 | 4,46 | 1.396 |
| 2026-01-27 | 1.290 | 4,75 | 6.128 |
| 2026-01-26 | 338 | 4,76 | 1.609 |
| 2026-01-23 | 338 | 4,84 | 1.636 |
| 2026-01-20 | 1.935 | 4,41 | 8.533 |
| 2026-01-06 | 20.319 | 4,18 | 84.933 |
| 2026-01-05 | 22.208 | 4,28 | 95.050 |
| 2026-01-02 | 201.946 | 4,18 | 844.134 |
| 2025-12-22 | 95.494 | 4,32 | 412.534 |
| 2025-12-19 | 4.199 | 4,17 | 17.510 |
| 2025-12-18 | 249.411 | 3,98 | 992.656 |
| 2025-12-17 | 44.621 | 3,87 | 172.683 |
| 2025-12-16 | 17.764 | 3,81 | 67.681 |
| 2025-12-15 | 14.449 | 3,69 | 53.317 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 14.06.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.